Respiratory intensive care unit of pseudomonas aeruginosa resistance monitoring and analysis of drug use

YAN Feng,CUI Rong,LUO Wen-Ling,WANG Rui-qin
DOI: https://doi.org/10.3969/j.issn.1009-6663.2009.04.013
2009-01-01
Abstract:Objective To understand the respiratory intensive care unit of 20 Pseudomonas aeruginosa antibiotic resistance, the amount of antibiotic resistance and the relationship between analysis and the guidance of the rational drug use.Methods The data were retrieved from January 2005 to January 2008 in the ward of our hospital with PAE of 20 antibiotics sensitivity test, and RICU 3 years in the seven kinds of antibiotics, the use of these drugs on the resistance of PAE for the statistical analysis.Results PAE was most sensitive to piperacillin /tazobactam, and the resistance rate was 12.5%. The resistance rates more than 90% were ampicillin, cefalotin, cefoxitin, determination of well, and cephalosporins. Three generations of cephalosporins was most sensitive to ceftazidime, and the quinolone resistance rate was less than 35%, among them the lowest was ciprofloxacin resistance. Aminoglycoside and imipenem resistance rates increased yearly and imipenem resistance rate was 46.5%. IPM, CAZ, AMK, CIP, ofloxacin (OFL), using pseudomonas aeruginosa, and drug resistance frequency (DDDs), showed significant positive correlations (r=1,P<0.01). AMC, PIP, the amount of resistance were not related.Conclusion RICU resistance in pseudomonas aeruginosa become an increasingly prominent issue.We must strengthen the resistance testing, with a recommendation on the use of combination of anti-Pseudomonas β lactam, an anti-aeruginosa or the fluoroquinolones aminoglycoside combined.
What problem does this paper attempt to address?